Preview Mode Links will not work in preview mode

ACC CardiaCast

Jun 29, 2018

This podcast discusses new data pertaining to the class of SGLT2 inhibitors in the treatment of diabetes and its cardioprotective properties. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the results of the EMPA-REG OUTCOME (Empagliflozin Cardiovascular Outcome Event Trial in...


Jun 15, 2018

This podcast discusses controversies in lipid management, including the safety of very low low-density lipoprotein cholesterol levels, the role of PCSK9 in high-risk patients for primary prevention, and the use of formal risk assessment and imaging in primary prevention.